526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis

Bibliographic Details
Main Authors: Ronnie Shapira-Frommer, Robert Segal, Gal Markel, Nethanel Asher, Ayala Tamir, Hagit Harati, Ronen Stoff, Shirly Grynberg, Adam Ostrowski, Lawrence Florin
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1831757012191412224
author Ronnie Shapira-Frommer
Robert Segal
Gal Markel
Nethanel Asher
Ayala Tamir
Hagit Harati
Ronen Stoff
Shirly Grynberg
Adam Ostrowski
Lawrence Florin
author_facet Ronnie Shapira-Frommer
Robert Segal
Gal Markel
Nethanel Asher
Ayala Tamir
Hagit Harati
Ronen Stoff
Shirly Grynberg
Adam Ostrowski
Lawrence Florin
author_sort Ronnie Shapira-Frommer
collection DOAJ
first_indexed 2024-12-22T00:23:55Z
format Article
id doaj.art-2ac901a7449f435f9fa9ba8ed5696e81
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-22T00:23:55Z
publishDate 2021-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-2ac901a7449f435f9fa9ba8ed5696e812022-12-21T18:45:06ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.526526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresisRonnie Shapira-Frommer0Robert Segal1Gal Markel2Nethanel Asher3Ayala Tamir4Hagit Harati5Ronen Stoff6Shirly Grynberg7Adam Ostrowski8Lawrence Florin9Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel3Immunicom Inc., San Diego, CA, USAElla Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, IsraelElla Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel1Sheba Medical Center, Israel, Ramat Gan, Israel2Sheba Medical Center, Ramat Gan, Israel2Sheba Medical Center, Ramat Gan, Israel2Sheba Medical Center, Ramat Gan, Israel3Immunicom Inc., San Diego, CA, USA3Immunicom Inc., San Diego, CA, USA
spellingShingle Ronnie Shapira-Frommer
Robert Segal
Gal Markel
Nethanel Asher
Ayala Tamir
Hagit Harati
Ronen Stoff
Shirly Grynberg
Adam Ostrowski
Lawrence Florin
526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
Journal for ImmunoTherapy of Cancer
title 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
title_full 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
title_fullStr 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
title_full_unstemmed 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
title_short 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis
title_sort 526 removal of soluble tumor necrosis factors receptors 1 2 in patients with metastatic solid tumors using immune apheresis
work_keys_str_mv AT ronnieshapirafrommer 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT robertsegal 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT galmarkel 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT nethanelasher 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT ayalatamir 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT hagitharati 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT ronenstoff 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT shirlygrynberg 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT adamostrowski 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis
AT lawrenceflorin 526removalofsolubletumornecrosisfactorsreceptors12inpatientswithmetastaticsolidtumorsusingimmuneapheresis